251 related articles for article (PubMed ID: 12537661)
1. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
Pandey UB; Phadke S; Mittal B
Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
[TBL] [Abstract][Full Text] [Related]
2. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
[TBL] [Abstract][Full Text] [Related]
3. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
Barros Santos C; Gonçalves Pimentel MM
Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
[TBL] [Abstract][Full Text] [Related]
4. Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation.
Milà M; Sànchez A; Badenas C; Brun C; Jiménez D; Villa MP; Castellví-Bel S; Estivill X
Hum Genet; 1997 Oct; 100(5-6):503-7. PubMed ID: 9341861
[TBL] [Abstract][Full Text] [Related]
5. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
Sharma D; Gupta M; Thelma BK
Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
[TBL] [Abstract][Full Text] [Related]
6. A new PCR assay useful for screening of FRAXE/FMR2 mental impairment among males.
Santos CB; Costa Lima MA; Pimentel MM
Hum Mutat; 2001 Aug; 18(2):157-62. PubMed ID: 11462240
[TBL] [Abstract][Full Text] [Related]
7. FRAXE mutation in mentally retarded patients using the OxE18 probe.
Mulatinho MV; Llerena JC; Pimentel MM
Int J Mol Med; 2000 Jan; 5(1):67-9. PubMed ID: 10601577
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the fragile X syndrome in Yugoslav patients with non-specific mental retardation.
Major T; Culjkovic B; Stojkovic O; Gucscekic M; Lakic A; Romac S
J Neurogenet; 2003; 17(2-3):223-30. PubMed ID: 14668200
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
[TBL] [Abstract][Full Text] [Related]
10. Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles.
Brown TC; Tarleton JC; Go RC; Longshore JW; Descartes M
Am J Med Genet; 1997 Dec; 73(4):447-55. PubMed ID: 9415473
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis and genetic counseling for fragile X mental retardation.
Pandey UB; Phadke SR; Mittal B
Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
[TBL] [Abstract][Full Text] [Related]
12. Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.
Biancalana V; Taine L; Bouix JC; Finck S; Chauvin A; De Verneuil H; Knight SJ; Stoll C; Lacombe D; Mandel JL
Am J Hum Genet; 1996 Oct; 59(4):847-54. PubMed ID: 8808600
[TBL] [Abstract][Full Text] [Related]
13. Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan.
Tzeng CC; Tzeng PY; Sun HS; Chen RM; Lin SJ
Diagn Mol Pathol; 2000 Jun; 9(2):75-80. PubMed ID: 10850542
[TBL] [Abstract][Full Text] [Related]
14. FMR2 expression in families with FRAXE mental retardation.
Gécz J; Oostra BA; Hockey A; Carbonell P; Turner G; Haan EA; Sutherland GR; Mulley JC
Hum Mol Genet; 1997 Mar; 6(3):435-41. PubMed ID: 9147647
[TBL] [Abstract][Full Text] [Related]
15. [From gene to disease; fragile X-syndrome: hereditary mental retardation due to a developmental gene].
de Vries LB; Oostra BA
Ned Tijdschr Geneeskd; 2001 Mar; 145(10):474-6. PubMed ID: 11268909
[TBL] [Abstract][Full Text] [Related]
16. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
Mandel JL; Biancalana V
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CGG/GCC repeats at the FMR1 and FMR2 genes in an Indian population with mental retardation of unknown etiology.
Katikala L; Guruju MR; Madireddi S; Vallamkonda O; Vallamkonda N; Persha A; Spurgeon AM
Genet Test Mol Biomarkers; 2011 Apr; 15(4):281-4. PubMed ID: 21254876
[TBL] [Abstract][Full Text] [Related]
18. [New methods for the diagnosis of fragile X syndrome: a study of the FMRP in blood and hair].
Ramos-Fuentes FJ
Rev Neurol; 2001 Oct; 33 Suppl 1():S9-S13. PubMed ID: 12447812
[TBL] [Abstract][Full Text] [Related]
19. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of FRAXE-positive subjects with mental impairement in two unrelated Italian families.
Russo S; Selicorni A; Bedeschi MF; Natacci F; Viziello P; Fortuna R; Pagani G; Dalprà L; Larizza L
Am J Med Genet; 1998 Jan; 75(3):304-8. PubMed ID: 9475603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
